Cytokine


. 2024 Mar 29:178:156583.
doi: 10.1016/j.cyto.2024.156583. Online ahead of print. Serum VEGF-A levels on admission in COVID-19 patients correlate with SP-D and neutrophils, reflecting disease severity: A prospective study

Mayoko Tsuji 1 , Mitsuko Kondo 2 , Yasuto Sato 3 , Azusa Miyoshi 2 , Fumi Kobayashi 2 , Ken Arimura 2 , Kaoru Yamashita 4 , Satoshi Morimoto 4 , Naoko Yanagisawa 5 , Atsuhiro Ichihara 4 , Etsuko Tagaya 2



AffiliationsAbstract

Background and objective: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant global morbidity and mortality. This study aimed to investigate the clinical significance of serum vascular endothelial growth factor A (VEGF-A) in COVID-19 patients and its association with disease severity and pulmonary injury.
Methods: We prospectively collected data from 71 hospitalized COVID-19 patients between June 2020 and January 2021. Patients were classified as either mild or severe based on their oxygen requirements during hospitalization. Serum VEGF-A levels were measured using an ELISA kit.
Results: In comparison to mild cases, significantly elevated serum VEGF-A levels were observed in severe COVID-19 patients. Furthermore, VEGF-A levels exhibited a positive correlation with white blood cell count, neutrophil count, and lymphocyte count. Notably, serum surfactant protein-D (SP-D), an indicator of alveolar epithelial cell damage, was significantly higher in patients with elevated VEGF-A levels.
Conclusion: These results suggest that elevated serum VEGF-A levels could serve as a prognostic biomarker for COVID-19 as it is indicative of alveolar epithelial cell injury caused by SARS-CoV-2 infection. Additionally, we observed a correlation between VEGF-A and neutrophil activation, which plays a role in the immune response during endothelial cell injury, indicating a potential involvement of angiogenesis in disease progression. Further research is needed to elucidate the underlying mechanisms of VEGF-A elevation in COVID-19.

Keywords: Angiogenesis; Lung; Neutrophil activation; SP-D; VEGF-A.

‚Äč